Promising sequencing contender Oxford Nanopore and market leader Illumina sever financial ties
Two closely watched genetic sequencing technology firms who had been unhappily affiliated have now divorced. UK-based Oxford Nanopore announced on 15 November that it has raised £56.4 million – mostly by selling the 13.5% of its shares that had been owned by San Diego-based Illumina since 2009. Read more
